Regorafenib from MedChemExpress

Product Specs
ItemRegorafenib
CompanyMedChemExpress
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberHY-10331
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.65%
FormulaC21H15ClF4N4O3
Research AreaCancer
TypeChemical
Molecular Weight482.82
Quantity10 mM * 1 mL
Molecule NameRegorafenib

Add to Compare List

MedChemExpress

1 Deer Park Dr, Suite Q

Monmouth Junction, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial-Mesenchymal Transition and Stemness PropertiesInt J Mol SciDecember 18, 2023Feng-Che Kuan, Jhy-Ming Li, Yun-Ching Huang, Shun-Fu Chang, Chung-Sheng Shidark at 2–8 °C. Regorafenib was purchased from the MedChemExpress (Monmouth Junction, NJ, USA; Cat. #HY-10331). Regorafenib was dissolved in DMSO (Merck, Darmstadt, Germany; Cat. #67-68-5) at a final concentration

(2) Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancerFrontiers in PharmacologyApril 17, 2023Tao Yuan, Ruilin Wu, Weihua Wang, Yue Liu, Wencheng Kong, Bo Yang, Qiaojun He, Hong Zhumaintained at 37°C in a humidified atmosphere containing 5% CO2. 2.2 Reagents and antibodies Regorafenib (HY-10331), Rosuvastatin Calcium (HY-17504) and Z-VAD-FMK (HY-16658B) were purchased from MedChemExpress. Both

(3) Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenograftsFrontiers in OncologySeptember 21, 2022Preeti Kanikarla Marie et al.administered intraperitoneally every 5 days at 20 mg per kg body weight for 25 days. Regorafenib (#HY-10331, MedChemExpress LLC) was administered orally every day at 10 mg per kg body weight for 25 days. Humanized

(4) s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand–foot skin reaction that can be reversed by nicotinamideCell ResearchSeptember 1, 2020Peihua Luo et al.saline in vitro and in vivo. Cycloheximide (CHX; MedChemExpress, HY-12320), regorafenib (MedChemExpress, HY-10331), Anlotinib (gift from CHIATAI TIANQING (China) Ltd) and marimastat (MedChemExpress, HY-12169) were

(5) Teaching on the run: teaching skills for surgical traineesANZ journal of surgeryJanuary 1, 2001Abu-Zidan FM.

Be the First to Write a Review!

Regorafenib from MedChemExpress

Description

MedChemExpress

Citations (5)

Reviews

Regorafenib from MedChemExpress

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map